Current Approaches to the Treatment of Hunter Syndrome

Current Approaches to the Treatment of Hunter Syndrome

Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is an X-linked hereditary disorder associated with a deficiency of iduronate2-sulfatase (IDS). IDS deficiency provokes the accumulation of dermatan sulfate and heparan sulfate in different tissues. Clinical manifestations of MPS II are heteroge...

Cijeli opis

Bibliografski detalji
Glavni autori: Ekaterina Yu. Zakharova, Elena Yu. Voskoboeva, Alla N. Semyachkina, Nato D. Vashakmadze, Amina I. Gamzatova, Svetlana V. Mikhailova, Sergey I. Kutsev
Format: Članak
Jezik:Russian
Izdano: Union of pediatricians of Russia 2018-10-01
Serija:Педиатрическая фармакология
Teme:
hunter syndrome
mucopolysaccharidosis type ii
enzyme replacement therapy
gene therapy
hematopoietic stem cell transplantation
Online pristup:https://www.pedpharma.ru/jour/article/view/1653

Internet

https://www.pedpharma.ru/jour/article/view/1653

Slični predmeti